Home
About
FAQ
History (9)
Timing of return office visit affects adherence to topical treatment in patients with atopic dermatitis: an analysis of 5 studies.
Predictors of delayed transition from central venous catheter use to permanent vascular access among ESRD patients.
Pentachlorophenol
Targeting protein homodimerization: a novel drug discovery system.
Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery
See All 9 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Establishment of a First-in-Class Biocompatible and Efficient Cryopreservation Technology Platform for the Next Generation of Cell-Based Therapeutics in Regenerative Medicine and Drug Discovery
Biography
contributor
Principal Investigator
Overview
sponsor award id
R44OD035392
Time
start date
2024-09-15
end date
2026-08-31